Log in to save to my catalogue

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be...

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2420135172

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

About this item

Full title

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Publisher

United States: Wolters Kluwer

Journal title

The American journal of gastroenterology, 2020-07, Vol.115 (7), p.1066-1074

Language

English

Formats

Publication information

Publisher

United States: Wolters Kluwer

More information

Scope and Contents

Contents

In primary biliary cholangitis (PBC), bilirubin and alkaline phosphatase (ALP) are widely established as independent predictors of prognosis. Current treatment goals do not aim for normalization of surrogate markers because their association with survival has not been defined.
The patient cohort from the GLOBAL PBC Study Group was used, comprisi...

Alternative Titles

Full title

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2420135172

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2420135172

Other Identifiers

ISSN

0002-9270

E-ISSN

1572-0241

DOI

10.14309/ajg.0000000000000557

How to access this item